OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
Keren Esther Kristina Mantik, Sujin Kim, Bonsang Gu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11450-11450
Open Access | Times Cited: 17

Showing 17 citing articles:

The growing range of complications of diabetes mellitus
Peter Shane Hamblin, Anthony Russell, Stella Talic, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 2

Evolving therapeutic interventions for the management and treatment of Alzheimer’s disease
Faizan Ahmad, Anik Karan, Rashi Sharma, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102229-102229
Closed Access | Times Cited: 15

Mitochondrial DNA and Inflammation in Alzheimer’s Disease
Giacoma Galizzi, Marta Di Carlo
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8586-8606
Open Access | Times Cited: 18

Exosomes in the Diagnosis of Neuropsychiatric Diseases: A Review
Song Wu, Xin-miao Shang, Meng Guo, et al.
Biology (2024) Vol. 13, Iss. 6, pp. 387-387
Open Access | Times Cited: 5

Diabetic retinopathy: New concepts of screening, monitoring, and interventions
Stephen H. Sinclair, Stan Schwartz
Survey of Ophthalmology (2024) Vol. 69, Iss. 6, pp. 882-892
Open Access | Times Cited: 5

Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets
Aparna Chauhan, Sachin Dubey, Smita Jain
Cell Biochemistry and Function (2024) Vol. 42, Iss. 7
Closed Access | Times Cited: 5

Interventions of cognitive impairment in older adults: A comprehensive review
Shivani Chib, Kajal Sharma, Randhir Singh
Aging and Health Research (2025), pp. 100223-100223
Open Access

Multi-target approach to Alzheimer’s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms
Kashif Abbas, Mohd Rais Mustafa, Mudassir Alam, et al.
Neurogenetics (2025) Vol. 26, Iss. 1
Closed Access

Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders
Laura Mihaela Isop, Andrea Elena Neculau, Radu Necula, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1714-1714
Open Access | Times Cited: 10

The dark side of drug repurposing. From clinical trial challenges to antimicrobial resistance: analysis based on three major fields
Iyad Natsheh, Majd M. Alsaleh, Ahmad Khalaf Alkhawaldeh, et al.
Drug Target Insights (2024) Vol. 18, Iss. 1, pp. 8-19
Open Access | Times Cited: 3

Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues
Vera Battini, María Antonietta Barbieri, Carla Carnovale, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3417-3425
Open Access | Times Cited: 2

Role of the Insulin-like Growth Factor System in Neurodegenerative Disease
Moira Lewitt, Gary W. Boyd
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4512-4512
Open Access | Times Cited: 2

Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer’s disease
Noor Abdulhameed, Alice Babin, Kim M. Hansen, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Associations between antidiabetic medications and cerebrospinal fluid biomarkers of Alzheimer's disease
Gemma García‐Lluch, Anna Marseglia, Lucrecia Moreno, et al.
Journal of Alzheimer s Disease (2024)
Closed Access | Times Cited: 1

Agonistes des récepteurs GLP-1 dans la maladie d’Alzheimer : Potentiel thérapeutique et mécanismes d’action
Benyaich Abdelhay, Aksissou Mustapha, Elkhattabi Lamiae, et al.
Médecine des Maladies Métaboliques (2024)
Closed Access

Physico-Chemical Characterization and Initial Evaluation of Carboxymethyl Chitosan–Hyaluronan Hydrocolloid Systems with Insulin Intended for Intranasal Administration
Roxana Popescu, Cristina-Elena Dinu-Pîrvu, Mihaela Violeta Ghica, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10452-10452
Open Access

Protective effects of berberine against diabetes-associated cognitive decline in mice
Mrinal Gupta, Mohammad Rumman, Babita Singh, et al.
Acta Diabetologica (2024)
Closed Access

Page 1

Scroll to top